A Phase III Observer Blind Single-Coordinating Center Pediatric Study in China Comparing a Booster Dose of Vaxem Hib to HIBERIX When Given as Part of a Local Dosing Regimen in Infants.
Phase of Trial: Phase III
Latest Information Update: 22 Aug 2013
At a glance
- Drugs TAK 816 (Primary) ; Hib vaccine conjugate
- Indications Haemophilus infections
- Focus Pharmacodynamics
- Sponsors Novartis
- 22 Aug 2013 Results published in the International Journal of Clinical Practice.
- 28 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History